Clinical trial · Interventional
Supportive Care Delivered by Telemedicine to Cancer Patients at Home
Virtual Visits by Supportive Care Specialists to Cancer Patients at Home: A Randomized Controlled Pilot Noninferiority Trial of Video Telemedicine
NCT04136340CI-TRIAL-00091835completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will test whether supportive care follow-up delivered to cancer patients at home by telemedicine ("virtual" medical visits using telecommunications technologies) is as effective as in-person supportive care visits in the clinic.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Supportive Care | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| In-person in clinic follow-up visit | Other | — | UNRESOLVED |
| Telemedicine follow-up visit | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- In-person follow-up
- description
- Due to the COVID-19 pandemic, patients originally randomized to the in-person group received telemedicine visits. Thus, the researchers will expand our sample for these interviews to include patients who have completed at least 2 telemedicine follow-up visits whether they were originally randomized to the in-person group or the home telemedicine group.
- interventionNames
- Other: In-person in clinic follow-up visit
- type
- EXPERIMENTAL
- label
- Home Telemedicine follow-up
- interventionNames
- Other: Telemedicine follow-up visit
Primary outcomes (1)
- measure
- Health-Related Quality of Life: FACT-G
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * age 18 years or older * solid tumor of any type * completed an initial in-person clinic visit (i.e. an IR/NV or AFX visit) at Rockefeller Outpatient Pavilion with Dr. Saldivar, Dr. Martin, Supportive Care physicians, or Andrea Dolan, a Supportive Care nurse practitioner * planned for Supportive Care Service follow-up visits, but none yet completed * enrolled on the MyMSK secure online patient portal and have access to the portal off site of MSK campuses * resident of New York or New Jersey or Connecticut (clinicians may not be licensed in other states, as would be required for televisits to patients there) Exclusion Criteria: * Patients and informal caregivers who cannot communicate with clinicians/respond to instruments in English without the use of an interpreter
References
Publications (0)
Data not yet available
No reference posted for this study.